Ganga Pharmaceuticals logo

Ganga Pharmaceuticals

GANGAPHARMACEUTICALSLTD NSE

Key Fundamentals

SMEPharmaceuticalsHealthcare
Market Cap
₹7.40 Cr
Volatility
Low Risk
P/E Ratio
73.5
EBITDA
₹0.30 Cr
Return on Equity
1.22%
Debt to Equity
0.13
Book Value
₹14.06
EPS
₹0.05
52W High
₹13.97
52W Low
₹9.35

Tapetide Score

Data-driven rating, 0–100. How it works →

Key Insights

Strengths

2
  • Company has reduced debt.
  • Stock is trading at 0.89 times its book value

Weaknesses

4
  • Though the company is reporting repeated profits, it is not paying out dividend
  • The company has delivered a poor sales growth of 3.30% over past five years.
  • Company has a low return on equity of 1.09% over last 3 years.
  • Promoter holding has decreased over last 3 years: -15.8%

Growth Rate

Revenue Growth
0% lower than 3Y
Net Income Growth
0% lower than 3Y
Cash Flow Change
-126% lower than 3Y
ROE
9.91% higher than 3Y
ROCE
-15.9% lower than 3Y
EBITDA Margin (Avg.)
-1.54% lower than 3Y

Quarterly Results

Particulars Mar 2020Sep 2020Mar 2021Sep 2021Mar 2022Sep 2022Mar 2023Sep 2023Mar 2024Sep 2024Mar 2025Sep 2025Mar 2026
Sales
1.7
1.14
1.23
1.25
1.24
1.35
1.23
1.32
1.42
1.31
1.33
1.37
1.46
Expenses
1.6
1.07
1.28
1.23
1.23
1.28
1.3
1.27
1.41
1.42
1.33
1.39
1.39
Operating Profit
0.1
0.07
-0.05
0.02
0.01
0.07
-0.07
0.05
0.01
-0.11
0
-0.02
0.07
OPM %
5.88%
6.14%
-4.07%
1.6%
0.81%
5.19%
-5.69%
3.79%
0.7%
-8.4%
0%
-1.46%
4.79%
Other Income
0.09
0.07
0.19
0.11
0.15
0.12
0.18
0.09
0.15
0.29
0.14
0.15
0.13
Interest
0.12
0.09
0.1
0.1
0.09
0.12
0.07
0.09
0.09
0.09
0.09
0.07
0.07
Depreciation
0.03
0.03
0.03
0.03
0.03
0.03
0.03
0.03
0.02
0.02
0.02
0.03
0.03
PBT
0.04
0.02
0.01
0
0.04
0.04
0.01
0.02
0.05
0.07
0.03
0.03
0.1
Tax %
25%
50%
100%
—
25%
25%
0%
50%
20%
57.14%
-66.67%
33.33%
20%
Net Profit
0.03
0.02
0
0
0.03
0.03
0.01
0.02
0.03
0.02
0.06
0.02
0.08
EPS in Rs
0.07
0.05
0
0
0.07
0.07
0.02
0.05
0.06
0.04
0.12
0.03
0.14
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales
2.44
2.45
2.63
2.73
3.18
2.99
2.27
2.32
2.47
2.58
2.48
2.67
Expenses
2.19
2.15
2.32
2.41
2.76
2.61
2.24
2.28
2.47
2.53
2.6
2.63
Operating Profit
0.25
0.3
0.31
0.32
0.42
0.38
0.03
0.04
0
0.05
-0.12
0.04
OPM %
10.25%
12.24%
11.79%
11.72%
13.21%
12.71%
1.32%
1.72%
0%
1.94%
-4.84%
1.5%
Other Income
0.17
0.14
0.16
0.15
0.14
0.17
0.25
0.26
0.3
0.24
0.44
0.28
Interest
0.33
0.33
0.32
0.28
0.25
0.24
0.19
0.19
0.19
0.18
0.18
0.13
Depreciation
0.04
0.04
0.04
0.06
0.05
0.05
0.05
0.05
0.06
0.05
0.05
0.06
PBT
0.05
0.07
0.11
0.13
0.26
0.26
0.04
0.06
0.05
0.06
0.09
0.13
Tax %
40%
28.57%
27.27%
23.08%
30.77%
23.08%
50%
16.67%
40%
33.33%
11.11%
23.08%
Net Profit
0.03
0.05
0.07
0.09
0.19
0.19
0.02
0.04
0.04
0.05
0.08
0.1
EPS in Rs
0.13
0.12
0.17
0.22
0.47
0.47
0.05
0.1
0.1
0.1
0.17
0.17
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
2.33
4.06
4.06
4.06
4.06
4.06
4.06
4.06
4.06
4.84
4.84
5.91
Reserves
0.31
0.74
0.81
0.91
1.09
1.29
1.31
1.35
1.39
2.21
2.29
2.4
Borrowings
2.14
2.19
2.14
2.05
1.87
1.47
1.73
1.93
1.83
1.36
1.42
1.09
Other Liabilities
0.61
0.35
0.6
1.22
0.74
0.75
0.56
0.66
0.71
0.24
0.42
0.25
Total Liabilities
5.39
7.34
7.61
8.24
7.76
7.57
7.66
8
7.99
8.65
8.97
9.65
Fixed Assets
0.65
0.62
0.62
0.82
0.8
0.76
0.72
0.68
0.64
0.61
0.66
0.65
CWIP
0
0
0
0
0
0
0
0
0
0
0
0
Investments
0.05
0.5
0
0
0.09
0.09
0.09
0.09
0.09
0.09
0
0
Other Assets
4.69
6.22
6.99
7.42
6.87
6.72
6.85
7.23
7.26
7.95
8.31
9
Total Assets
5.39
7.34
7.61
8.24
7.76
7.57
7.66
8
7.99
8.65
8.97
9.65
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
0.27
-1.05
0.05
0.24
0.11
-0.31
-0.18
-0.21
-0.04
-1.26
-0.58
-1.31
Investing
-0.18
-0.83
0.62
-0.14
0.28
0.37
0.28
0.19
0.49
0.13
1.18
0.24
Financing
-0.06
1.9
-0.33
-0.36
-0.45
-0.29
-0.1
0.03
-0.44
1.14
-0.33
0.82
Net Cash Flow
0.03
0.02
0.33
-0.26
-0.05
-0.22
0
0.01
0.01
0
0.27
-0.24
Free Cash Flow
0.23
-1.06
0.01
-0.02
0.08
-0.32
-0.2
-0.22
-0.05
-1.28
-0.68
-1.35
CFO/OP
104
-347
29
88
40
-66
-567
-500
—
-2,480
467
-3,200
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
109
140
173
211
141
131
132
140
132
130
134
129
Inventory Days
288
375
386
359
341
297
333
331
347
362
353
329
Days Payable
118
98.65
183
330
163
160
130
152
171
29.2
83.77
33.69
Cash Conversion Cycle
279
416
377
240
319
267
335
318
308
463
403
423
Working Capital Days
142
468
429
417
388
449
478
503
477
639
731
856
ROCE %
8.03%
6.8%
6.14%
5.84%
7.26%
7.23%
3.3%
3.46%
3.28%
3.06%
3.18%
2.9%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Ganga Pharmaceuticals insights

57 extracted metrics + investor summaries across FY15–FY26.

Log in — free

Shareholding Pattern

Promot.50.91%Others13.77%Public35.32%As ofMar 2026

Documents

Frequently Asked Questions about Ganga Pharmaceuticals

What does Ganga Pharmaceuticals Ltd do?
Incorporated in 1989, Ganga Pharmaceuticals Ltd manufactures & trades in Pharmaceuticals & allied products (Ayurveda)[1]
Where is Ganga Pharmaceuticals Ltd (539680) listed?
Ganga Pharmaceuticals Ltd trades as GANGAPHARMACEUTICALSLTD on the NSE and under code GANGAPHARM on the BSE.
Which sector does Ganga Pharmaceuticals Ltd belong to?
Ganga Pharmaceuticals Ltd is classified under the Healthcare sector, in the Pharmaceuticals industry.
What is the market capitalisation of Ganga Pharmaceuticals Ltd?
Ganga Pharmaceuticals Ltd has a market capitalisation of ₹7.4 Cr, which places it in the Small Cap band.
What is the PE ratio of Ganga Pharmaceuticals Ltd?
Ganga Pharmaceuticals Ltd trades at a PE ratio of 73.50, on earnings per share of ₹0.05, against a book value of ₹14.06 per share.
What is the 52-week high and low of Ganga Pharmaceuticals Ltd?
Over the last 52 weeks Ganga Pharmaceuticals Ltd has traded between ₹9.35 and ₹13.97.
What is the Return on Equity (ROE) of Ganga Pharmaceuticals Ltd?
Ganga Pharmaceuticals Ltd reported a return on equity of 1.22%. Its debt-to-equity ratio is 0.13.

Company Information

Incorporated in 1989, Ganga Pharmaceuticals Ltd manufactures & trades in Pharmaceuticals & allied products (Ayurveda)[1]

Website ayurvedganga.com
Listed 2016-02-22
Face Value ₹ 10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/539680.md for Ganga Pharmaceuticals Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our MCP server.

Explore More

More in Healthcare → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List